Abstract
Recombinant technology has been employed to study the cephalosporin C pathway and enhance the activity of a rate-limiting enzyme, DAOCS, in Cephalosporium acremonium.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have